Organigram Appoints Senior Vice President of Marketing
May 31 2021 - 06:00AM
Business Wire
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX:
OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a
leading producer of cannabis, is pleased to announce the
appointment of Megan McCrae as the Company’s Senior Vice President
of Marketing and Communications. Ms. McCrae will assume her new
role effective today.
A seasoned marketing expert, Ms. McCrae has 17 years experience
in consumer packaged goods marketing and sales management, brand
building and consumer insights.
Ms. McCrae is a cannabis industry veteran, having most recently
served as Chief Marketing Officer of Aphria Inc. where she led the
company’s brand and product strategy including brand and portfolio
management, consumer insights, innovation and digital strategy. Ms.
McCrae also spent ten years in various global progressive consumer
and trade marketing management roles with Japan Tobacco
International, a major global tobacco company.
Ms. McCrae also held the position of Board Chair on the Cannabis
Council of Canada where she worked closely with industry leaders
and regulators, including Health Canada, on advocacy efforts to
advance the Canadian cannabis industry nationally and globally.
“We are exceptionally pleased to welcome Megan to the Organigram
team,” says Peter Amirault, Executive Chair, Organigram. “Megan’s
tremendous marketing expertise and insight, as well as her personal
commitment to the growth of Canada’s cannabis market, will help set
a powerful strategic roadmap for the future of Organigram’s
established and emerging portfolio of brands and products.”
Ms. McCrae will be based in Ontario but will oversee
Organigram’s marketing efforts across the country. She holds a
Bachelor’s degree from Western University and is a graduate of
Richard Ivey School of Business.
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select Market and
TSX listed company whose wholly owned subsidiaries include:
Organigram Inc., a licensed producer of cannabis and
cannabis-derived products in Canada and The Edibles and Infusions
Corporation, a cannabis infused soft chew and confectionary
manufacturer in Canada.
Organigram is focused on producing high-quality, indoor-grown
cannabis for patients and adult recreational consumers in Canada,
as well as developing international business partnerships to extend
the Company's global footprint. Organigram has also developed a
portfolio of legal adult use recreational cannabis brands including
The Edison Cannabis Company, Indi, Bag o’ Buds, SHRED and
Trailblazer. Organigram's facility is located in Moncton, New
Brunswick with another leased manufacturing facility in Winnipeg,
Manitoba. The Company is regulated by the Cannabis Act and the
Cannabis Regulations (Canada).
This news release contains forward-looking information. Often,
but not always, forward-looking information can be identified by
the use of words such as “plans”, “expects”, “estimates”,
“intends”, “anticipates”, “believes” or variations of such words
and phrases or state that certain actions, events, or results
“may”, “could”, “would”, “might” or “will” be taken, occur or be
achieved. Forward-looking information involves known and unknown
risks, uncertainties and other factors that may cause actual
results, events, performance or achievements of Organigram to
differ materially from current expectations or future results,
performance or achievements expressed or implied by the
forward-looking information contained in this news release. Risks,
uncertainties and other factors involved with forward-looking
information could cause actual events, results, performance,
prospects and opportunities to differ materially from those
expressed or implied by such forward-looking information include
factors and risks as disclosed in the Company’s most recent annual
information form, management’s discussion and analysis and other
Company documents filed from time to time on SEDAR (see
www.sedar.com) and filed or furnished to the Securities and
Exchange Commission on EDGAR (see www.sec.gov). Readers are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date of this press release.
Although the Company believes that the assumptions and factors used
in preparing the forward-looking information in this news release
are reasonable, undue reliance should not be placed on such
information and no assurance can be given that such events will
occur in the disclosed time frames or at all. The forward-looking
information included in this news release are made as of the date
of this news release and the Company disclaims any intention or
obligation, except to the extent required by law, to update or
revise any forward-looking information, whether as a result of new
information, future events or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210531005043/en/
For Investor Relations enquiries: Amy Schwalm Vice
President, Investor Relations Amy.Schwalm@organigram.ca (416)
704-9057
For Media enquiries: Marlo Taylor
mtaylor@gagecommunications.ca
Organigram (NASDAQ:OGI)
Historical Stock Chart
From Feb 2024 to Mar 2024
Organigram (NASDAQ:OGI)
Historical Stock Chart
From Mar 2023 to Mar 2024